Pharmacokinetics of the NS3 Protease Inhibitor, Asunaprevir (ASV, BMS-650032), in Phase I Studies in Subjects With or Without Chronic Hepatitis C
Author:
Affiliation:
1. Bristol-Myers Squibb, Research and Development; Hopewell NJ USA
2. Bristol-Myers Squibb, Research and Development; Princeton NJ USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.52/fullpdf
Reference25 articles.
1. Hepatitis B virus epidemiology disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat.,2004
2. The global health burden of hepatitis C virus infection;Negro;Liver Int.,2011
3. World Health Organization http://www.who.int/mediacentre/factsheets/fs164/en/
4. World Health Organization http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index4.html
5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med.,2002
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C;PLOS ONE;2019-07-10
2. Modulation of chimeric antigen receptor surface expression by a small molecule switch;BMC Biotechnology;2019-07-03
3. The Discovery and Early Clinical Evaluation of the HCV NS3/4A Protease Inhibitor Asunaprevir (BMS-650032);Topics in Medicinal Chemistry;2019
4. Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy;PLOS ONE;2018-10-11
5. Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation;Anticancer Research;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3